Evogene Statistics Share Statistics Evogene has 8.71M
shares outstanding. The number of shares has increased by 31.9%
in one year.
Shares Outstanding 8.71M Shares Change (YoY) 31.9% Shares Change (QoQ) 24.35% Owned by Institutions (%) 7.75% Shares Floating 8.58M Failed to Deliver (FTD) Shares 3,039 FTD / Avg. Volume 0.16%
Short Selling Information The latest short interest is 151.73K, so 1.74% of the outstanding
shares have been sold short.
Short Interest 151.73K Short % of Shares Out 1.74% Short % of Float 1.74% Short Ratio (days to cover) 1.08
Valuation Ratios The PE ratio is -0.65 and the forward
PE ratio is -0.78.
Evogene's PEG ratio is
0.01.
PE Ratio -0.65 Forward PE -0.78 PS Ratio 1.25 Forward PS 0.8 PB Ratio -7.34 P/FCF Ratio -0.52 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Evogene.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.15,
with a Debt / Equity ratio of -8.87.
Current Ratio 1.15 Quick Ratio 1.06 Debt / Equity -8.87 Debt / EBITDA -0.83 Debt / FCF -0.63 Interest Coverage -179.11
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $72.74K Profits Per Employee $-140.9K Employee Count 117 Asset Turnover 0.21 Inventory Turnover 1.47
Taxes Income Tax 9K Effective Tax Rate -0.05%
Stock Price Statistics The stock price has increased by -68.81% in the
last 52 weeks. The beta is 1.42, so Evogene's
price volatility has been higher than the market average.
Beta 1.42 52-Week Price Change -68.81% 50-Day Moving Average 1.33 200-Day Moving Average 1.46 Relative Strength Index (RSI) 45 Average Volume (20 Days) 1,848,114
Income Statement In the last 12 months, Evogene had revenue of 8.51M
and earned -16.48M
in profits. Earnings per share was -2.89.
Revenue 8.51M Gross Profit 5.83M Operating Income -22.21M Net Income -16.48M EBITDA -15.48M EBIT -17.98M Earnings Per Share (EPS) -2.89
Full Income Statement Balance Sheet The company has 15.3M in cash and 12.87M in
debt, giving a net cash position of 2.43M.
Cash & Cash Equivalents 15.3M Total Debt 12.87M Net Cash 2.43M Retained Earnings -274.07M Total Assets 34.3M Working Capital 902K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -19.7M
and capital expenditures -626K, giving a free cash flow of -20.33M.
Operating Cash Flow -19.7M Capital Expenditures -626K Free Cash Flow -20.33M FCF Per Share -3.57
Full Cash Flow Statement Margins Gross margin is 68.48%, with operating and profit margins of -260.96% and -193.69%.
Gross Margin 68.48% Operating Margin -260.96% Pretax Margin -212.02% Profit Margin -193.69% EBITDA Margin -181.86% EBIT Margin -260.96% FCF Margin -238.82%
Dividends & Yields EVGN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for EVGN is $3.5,
which is 189.3% higher than the current price. The consensus rating is "Buy".
Price Target $3.5 Price Target Difference 189.3% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 25, 2024. It was a
backward
split with a ratio of 1:10.
Last Split Date Jul 25, 2024 Split Type backward Split Ratio 1:10
Scores Altman Z-Score -12.39 Piotroski F-Score 2
